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Editorial
I would like to announce the newest issue of “Nuclear Medicine 
Review”. The chapter “Original articles” opens with the paper writ-
ten by Polish colleagues who used a single intramuscular injection 
of a very low dose (0.03 mg) of recombinant human thyrotropin 
(rhTSH) which turned increasing the degree and homogeneity 
of radioactive iodine uptake in large multi-nodular goiter, both 
euthyroid and subclinically hyperthyroid. The authors concluded 
that administration of rhTSH before I-131 seems to be an optimal 
method of management which may increase the effectiveness of 
radioiodine treatment and decrease the exposure of the patients to 
absorbed doses of ionizing radiation. The second paper from Czech 
Republic concerned the verification of the 99mTc-DMSA planar 
scintigraphy accuracy for separate renal function assessment 
compared with an evaluation based on SPECT imaging with or 
without CT attenuation correction. The next two articles are written 
by Bulgarian scientists. The first one shows for the first time that 
the determining of the levels of free thyroxine (FT4) in the needle 
washout after fine-needle aspiration biopsy (FNAB) could be useful 
in the diagnosis of the hyperfunctioning thyroid nodules. The second 
one evaluated the ability of dual-time-point PET/CT to enhance 
sensitivity, specificity, accuracy, positive and negative predicting 
value of 18FDG PET/CT in high grade and low grade sarcomas. 
Two review articles come from Poland. Their authors elucidate 
the utility of 18F-FDG PET/CT in diagnosis and management of vas-
cular diseases and the development history of PET/MR scanners, 
the principle of their functioning, and their usefulness in oncological 
and non-oncological diagnostics. 
In this issue of Nuclear Medicine Review there are four inte-
resting clinical cases discussed. The authors from Iran described 
their first patient with Merkel Cell Carcinoma who underwent suc-
cessful sentinel node mapping. The next three clinical cases were 
presented by Polish physicians. The first one considers difficulties in 
diagnosis of parathyroid cancer. The second one demonstrates that 
nuclear medicine may be a valuable adjunct as it yields functional 
information and often provides reliable diagnosis before any radio-
logic abnormalities occur in patients with blunt chest trauma. And 
the third one describes the problems of diagnostic assessment in 
advanced pancreatic neuroendocrine neoplasm. 
In the end of my letter I would like to proudly inform you that 
the Polish Ministry of Science and High Education score of our 
journal has increased (from 7 to 12 points). We do our best to get 
the Impact Factor. Please note that the most important thing is the 
number of citations from the articles from Nuclear Medicine Review, 
especially those published during last two years. 
And in the very end I wish you a Happy New Year! 
Yours
Grzegorz Kamiński
Editor-in-Chief 
Nuclear Medicine Review
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